Paul Evans Email and Phone Number
Paul Evans work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Paul Evans personal email
Paul Evans phone numbers
Getting to the ‘Next Level’…It’s not a function of magic or luck. But rather … of desire, planning, and old-fashioned hard work.When a challenge is complex, uncertain, and uncharted, I’m the one that stakeholders ask to bring structure to turmoil and expect to get it done. This is a recurring theme throughout my 20-years as a pharmaceutical executive spanning both generic & specialty pharma and CDMOs. So, I’ve created a personal operating model – I call it RACE, for Reason, Action, Clarity, and Execution – delivering results even in the most chaotic of situations. “Paul gets it done.”Colleagues tell me I function as a servant-leader who enables employees to become the ‘best version of themselves’ – moving us to the next level.I’m blessed with an inner drive — an innate source of intensity, energy, and power that motivates me. I take immense satisfaction in being authentic, collaborative, and productive. “What you see in Paul is what you get.”I create VALUE by applying these core principles:ALIGNMENT | I believe that alignment holds people together, provides structure, a foundation, a framework within which to create and execute. I’m compelled to create alignment, so we all understand the “WHY” of our efforts – to turn our vision into reality, to integrate the “right thing” to do for the business with the “best thing” to do.CATALYSIS | A leader plays a pivotal role in the execution of Strategy - to catalyze the team so we execute within the realities of the moment. I act as that catalyst: guiding ... listening ... and connecting the dots so we take educated risks together and solve complex challenges.RESULTS | I believe real growth only occurs when results build upon prior results ... delivering both short-term and long-term wins. Together, we move forward and create.[For more details of the value I create, see nine (9) Examples in the PROJECT portion of my ACCOMPLISHMENT section below.]If you are looking to move your business to the ‘Next Level’, then let’s start a conversation!✆ 215. 431. 5022E | paul.j.evans@comcast.net
Pharmascience
View- Website:
- pharmascience.com
-
Vp - Global Business Development & PortfolioPharmascience Nov 2020 - PresentMontreal, Quebec, CaRecruited to lead global business development and portfolio for the generic and specialty brand divisions of Pharmascience Inc. Founded in 1983, Pharmascience is a full-service, privately-owned pharmaceutical company and is a leading manufacturer and marketer of prescription generic, over-the-counter, and behind-the-counter products as well as USFDA approved Canadian-made injectables. With strong roots in Canada and a growing global reach, the company distributes in more than 60 countries and commercializes nearly 300 product families in 20 different dosage forms for over 2,000 products. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products.MISSION |• Cultivate a growth-oriented culture to take Pharmascience to the next level.• Catalyze a diverse team to take entrepreneurial risks and accountability.• Collaborate cross-functionally to create alignment and drive results.IMPACT |• Successfully on-boarded, executed, built strong enterprise-wide relationships, and led transition to a growth-orientation in a 100%, fully remote environment.• Created value in 6 months by catalyzing team to deliver an additional 14 in-licensing agreements generating $60m in projected 5-yr margin and reducing operating expenses by $250k.• Collaborated cross-functionally to upgrade product selection process for global alignment and investment discipline.DEFINING COMPETENCIES |Senior-level Executive Leadership | Strategic Thinking | Complex Negotiations & Partnering | Global Business Development | M&A | Portfolio Management | Legal & IP Strategy
-
Founding PrincipalEvans Pharma Consulting Feb 2011 - PresentAfter the successful sale of Qualitest to Endo Pharmaceuticals, I formed a strategy and business development consultancy and advisory practice. I provide leadership with expertise relative to acquisition due-diligence, target search, commercial forecasting, partnering strategy, and contract execution. With a focus on the generic & specialty pharmaceutical and CDMO space, clients include private equity, established pharmaceutical companies and start-ups looking to move their businesses to the Next Level.IMPACT |• Advised private equity on fit & valuation for 4 potential acquisitions in the $100m - $1b range• Negotiated 3 new product supply relationships valued at $10-30m revenue with a focus on IP valuation• Drove client’s search process for acquisition targets DEFINING COMPETENCIES |Complex Negotiations & Partnering | Global Business Development | M&A | Legal & IP Strategy
-
Senior Advisor - Advisory BoardBenuvia Manufacturing Jan 2021 - Jan 2022Round Rock, Texas, Us -
Vp - Global Generic Products & Solutions, Health Sector; Vp & Gm - Jm Pharmaceutical VenturesJohnson Matthey Jul 2013 - Apr 2020London, Greater London, GbRecruited to lead a new venture within Johnson Matthey’s established fine chemical business. Traditionally, JM focused on supplying generic pharmaceutical companies with controlled-substance active pharmaceutical ingredients or contract development & manufacturing of APIs for innovator companies. This was an opportunity to doing something entrepreneurial – reinvigorating the pipeline of new generic APIs and changing the strategy to include drug product – to take the fine chemical business to the next level. Created a new team from scratch to focus on drug product profit-sharing partnerships; this success led to an integration with the broader business, with me stepping up to lead the global generic API business. IMPACT |• Created vision / strategic plan and obtained funding for new business unit by reviving new product pipeline and changing “go to market” strategy, including API sales and FDF profit-share partnerships.• Generated >$60m profit in 18 months by launching a profit-share partnership on new API / FDF.• Drove P&L with $250m revenue by establishing product management / strategies and cost to serve discipline. DEFINING COMPETENCIES |Senior-level Executive Leadership | Vision development | Strategic Thinking | Complex Negotiations & Partnering | Global Business Development | Portfolio Management | Legal & IP Strategy -
Senior Director - Business DevelopmentTeva Pharmaceuticals Feb 2012 - Jun 2013Tel-Aviv, IlLargest generic pharmaceutical company in the world. When I was asked to join, I thought it was a great opportunity to move my consulting practice into a full-time role across a broader range of dosage forms and markets. I worked with a great business development and alliance management team to fill holes in our US launch pipeline, mitigate launch risk and look for new products / companies that enhanced our capabilities around the world.IMPACT |• Executed partnering / in-licensing / M&A opportunities from ideation to close.• Championed and negotiated a complex manufacturing & distribution agreement for first-to-generic-market, cytotoxic chemotherapy with market value of $650m.• Negotiated and led technology license agreement for a peptide in a long-acting depot suspension with global market value of $1.6b.DEFINING COMPETENCIES |Strategic Thinking | Complex Negotiations & Partnering | Business Development -
Vp - Business DevelopmentQualitest Pharmaceuticals Sep 2009 - Feb 2011Huntsville, Al, UsI joined this privately-held generic pharmaceutical company soon after Apax Partners acquired the business from the founders. This was a ‘roll-up your sleeves’ role as the only business development team member in a small, but experienced and hard-charging, 8-member executive team. We worked to quickly scale EBITDA and were in constant deal-making mode – either licensing products, acquiring products, acquiring companies, or positioning ourselves for an exit.IMPACT |• Increased private company’s EBITDA by $23m by leading new product selection process, developing corporate strategy, and evaluating partnering / in-licensing M&A opportunities.• Advised and executed private equity exit, completing sale to Endo Pharmaceuticals.• Realized commercial product sales potential of $4m by closing 2 licensing agreements.DEFINING COMPETENCIES |Senior-level Executive Leadership | Strategic Thinking | Complex Negotiations & Partnering | Global Business Development | M&A | Portfolio Management | Legal & IP Strategy -
Vp - Strategic Partnering & Business DevelopmentAlita Pharmaceuticals, Inc. Dec 2006 - Aug 2009CEO recruited me as employee #2 at this specialty pharmaceutical start-up that was backed by Warburg-Pincus. Our focus was to build a branded portfolio of urology and female healthcare products - licensing assets with human proof of concept and then commercializing them by shepherding them through clinical development and scale-up. As a small start-up, our 5-member executive team was very hands-on and worked across functions to support each other in a collaborative way. IMPACT |• Built pipeline of phase 2 / 3 clinical NDA assets within 2 years, executing 3 licensing agreements with commercial product revenue potential of $900m.• Negotiated agreements for clinical trials, pharmacovigilance, product development, and supply.• Positioned commercialization strategy of clinical pipeline for Urologists and OB-GYNs.DEFINING COMPETENCIES |Senior-level Executive Leadership | Strategic Thinking | Complex Negotiations & Partnering | Global Business Development | Portfolio Management | Legal & IP Strategy
-
PresidentStada Pharmaceuticals, Inc. 2002 - 2006UsSTADA was an opportunity to pivot away from the active pharmaceutical ingredients segment - a chance to get involved in drug product business development. It was here that I discovered my affinity for leveraging partnerships to develop new generic drug products and align contract manufacturing arrangements. After heading up business development, I was asked to lead the subsidiary as its President until I helped STADA group exit the US market.IMPACT |• Drove $35m revenue base by directing new product launches and establishing accountability.• Spearheaded strategic reorganization, designing a self-sufficient, profitable business entity.• Prepared complete corporate due-diligence and pitch package for accomplishing sale of company.DEFINING COMPETENCIES |Senior-level Executive Leadership | Strategic Thinking | Complex Negotiations & Partnering | Global Business Development | Portfolio Management
Paul Evans Skills
Paul Evans Education Details
-
University Of PennsylvaniaChemical Engineering -
Drexel UniversityEngineering Management
Frequently Asked Questions about Paul Evans
What company does Paul Evans work for?
Paul Evans works for Pharmascience
What is Paul Evans's role at the current company?
Paul Evans's current role is C-LEVEL EXECUTIVE | Creating strategy and executing tactically to get Organizations to the "Next Level" | Providing balanced Leadership to increase Enterprise Value.
What is Paul Evans's email address?
Paul Evans's email address is pa****@****ric.net
What is Paul Evans's direct phone number?
Paul Evans's direct phone number is +160940*****
What schools did Paul Evans attend?
Paul Evans attended University Of Pennsylvania, Drexel University.
What skills is Paul Evans known for?
Paul Evans has skills like Leadership, Business Strategy, Portfolio Management, Intellectual Property, Business Development, Negotiation, Mergers And Acquisitions, Licensing.
Who are Paul Evans's colleagues?
Paul Evans's colleagues are Petya Handzhiyska, Eric Michaud, Ingrid Kolos, Mouhamadou Sy, Elise F., Aziz Zaki, Julie Morel.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial